BrainStorm Cell Therapeutics
BCLI
#10105
Rank
NZ$12.21 M
Marketcap
$1.87
Share price
14.87%
Change (1 day)
-86.27%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.97

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.99. In 2022 the company made an earnings per share (EPS) of -$1.10 an increase over its 2021 EPS that were of -$1.14.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.97-11.8%
2022-$1.10-2.94%
2021-$1.14-37.04%
2020-$1.811.89%
2019-$1.7751.43%
2018-$1.17159.26%
2017-$0.45-3.57%
2016-$0.47-37.78%
2015-$0.75-33.82%
2014-$1.1436%
2013-$0.8411.11%
2012-$0.7550%
2011-$0.50-50%
2010-$1.00-233.33%
2009$0.75-142.86%
2008-$1.76-65%
2007-$5.02
2005$1.66-108.03%
2004-$20.6213203.07%
2003-$0.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.34-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.51 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.70 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.86-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.42 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA